Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Exchange Rate Effect: 2010-2024

Historic Exchange Rate Effect for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$66,232.

  • China Pharma Holdings' Exchange Rate Effect rose 313.86% to $42,392 in Q3 2025 from the same period last year, while for Sep 2025 it was -$66,842, marking a year-over-year decrease of 237.98%. This contributed to the annual value of -$66,232 for FY2024, which is 307.46% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Exchange Rate Effect is -$66,232, which was down 307.46% from $31,925 recorded in FY2023.
  • China Pharma Holdings' 5-year Exchange Rate Effect high stood at $58,156 for FY2020, and its period low was -$247,573 during FY2022.
  • For the 3-year period, China Pharma Holdings' Exchange Rate Effect averaged around -$93,960, with its median value being -$66,232 (2024).
  • As far as peak fluctuations go, China Pharma Holdings' Exchange Rate Effect spiked by 403.23% in 2020, and later crashed by 2,833.68% in 2022.
  • Yearly analysis of 5 years shows China Pharma Holdings' Exchange Rate Effect stood at $58,156 in 2020, then slumped by 114.51% to -$8,439 in 2021, then tumbled by 2,833.68% to -$247,573 in 2022, then spiked by 112.90% to $31,925 in 2023, then slumped by 307.46% to -$66,232 in 2024.